Killian Hurley

2.8k total citations
26 papers, 653 citations indexed

About

Killian Hurley is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Killian Hurley has authored 26 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Killian Hurley's work include Protease and Inhibitor Mechanisms (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Neonatal Respiratory Health Research (4 papers). Killian Hurley is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and Neonatal Respiratory Health Research (4 papers). Killian Hurley collaborates with scholars based in Ireland, United States and United Kingdom. Killian Hurley's co-authors include Noel G. McElvaney, Emer P. Reeves, David A. Bergin, Brian W. Pickering, Brian Marsh, Rebecca Wolfe, E O’Brien, Darrell N. Kotton, Michael J. Herriges and Shou‐Wen Wang and has published in prestigious journals such as JAMA, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Killian Hurley

25 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Killian Hurley Ireland 12 203 173 157 98 93 26 653
Sandra Geiger Germany 11 152 0.7× 193 1.1× 88 0.6× 110 1.1× 84 0.9× 16 537
Angela J. Yoon United States 15 133 0.7× 216 1.2× 66 0.4× 125 1.3× 27 0.3× 56 631
Tian Tian China 19 97 0.5× 229 1.3× 242 1.5× 279 2.8× 128 1.4× 70 892
Elisabetta Petracci Italy 17 274 1.3× 282 1.6× 365 2.3× 480 4.9× 73 0.8× 62 1.1k
Anne L. King United States 22 144 0.7× 216 1.2× 160 1.0× 36 0.4× 88 0.9× 50 1.3k
Kaiu Prikk Estonia 13 175 0.9× 98 0.6× 293 1.9× 103 1.1× 64 0.7× 15 709
Mengyang Di United States 15 78 0.4× 129 0.7× 127 0.8× 303 3.1× 32 0.3× 54 770
Ceylan Eken Switzerland 10 147 0.7× 504 2.9× 54 0.3× 71 0.7× 379 4.1× 19 868
Aris Spathis Greece 20 85 0.4× 209 1.2× 272 1.7× 185 1.9× 138 1.5× 86 994

Countries citing papers authored by Killian Hurley

Since Specialization
Citations

This map shows the geographic impact of Killian Hurley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Killian Hurley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Killian Hurley more than expected).

Fields of papers citing papers by Killian Hurley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Killian Hurley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Killian Hurley. The network helps show where Killian Hurley may publish in the future.

Co-authorship network of co-authors of Killian Hurley

This figure shows the co-authorship network connecting the top 25 collaborators of Killian Hurley. A scholar is included among the top collaborators of Killian Hurley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Killian Hurley. Killian Hurley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hurley, Killian, Mari Ozaki, Quentin Philippot, et al.. (2024). A roadmap to precision treatments for familial pulmonary fibrosis. EBioMedicine. 104. 105135–105135. 2 indexed citations
2.
Kenny, Sarah, Irene Oglesby, Chiara De Santi, et al.. (2023). An evaluation of an open access iPSC training course: “How to model interstitial lung disease using patient-derived iPSCs”. Stem Cell Research & Therapy. 14(1). 377–377. 1 indexed citations
3.
Wang, Shou‐Wen, Michael J. Herriges, Killian Hurley, Darrell N. Kotton, & Allon M. Klein. (2022). CoSpar identifies early cell fate biases from single-cell transcriptomic and lineage information. Nature Biotechnology. 40(7). 1066–1074. 46 indexed citations
4.
Ozaki, Mari, et al.. (2022). Sexual Dimorphism in Interstitial Lung Disease. Biomedicines. 10(12). 3030–3030. 8 indexed citations
5.
Sun, Yuliang, Killian Hurley, Carlos Villacorta-Martín, et al.. (2021). Heterogeneity in Human Induced Pluripotent Stem Cell–derived Alveolar Epithelial Type II Cells Revealed with ABCA3/SFTPC Reporters. American Journal of Respiratory Cell and Molecular Biology. 65(4). 442–460. 26 indexed citations
6.
Oglesby, Irene, et al.. (2021). Lung organoids and other preclinical models of pulmonary fibrosis. QJM. 114(3). 167–173. 11 indexed citations
7.
Gribaldo, Laura, Killian Hurley, Pieter S. Hiemstra, & Catherine M. Greene. (2021). Increased focus on non-animal models for COVID-19 and non-COVID lung research. European Respiratory Journal. 57(1). 2004267–2004267. 1 indexed citations
8.
Oglesby, Irene, Darrell N. Kotton, Andrew Berical, et al.. (2021). MiRNA Expression and Modulation in iPSC Derived Lung Organoids. A4267–A4267. 1 indexed citations
9.
O’Brien, Helen, E O’Brien, Ross Morgan, et al.. (2020). An integrated multidisciplinary model of COVID-19 recovery care. Irish Journal of Medical Science (1971 -). 190(2). 461–468. 47 indexed citations
10.
Toomey, Sinéad, Stephen F. Madden, Michelle Casey, et al.. (2020). Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19). Thorax. 76(1). 86–88. 57 indexed citations
11.
Nash, David R., Ross Dunne, Aurélie Fabre, et al.. (2020). Isolated interstitial lung disease associated with anti-Ku autoantibodies: a case responding to a CD20 inhibitor. QJM. 114(4). 258–260. 1 indexed citations
12.
Hurley, Killian, Carlos Villacorta-Martín, Marall Vedaie, et al.. (2020). A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells. Stem Cell Reports. 15(1). 242–255. 17 indexed citations
13.
Hurley, Killian & George O'connor. (2018). Serum α1-Antitrypsin Concentration in the Diagnosis of α1-Antitrypsin Deficiency. JAMA. 319(19). 2034–2034. 6 indexed citations
14.
Hurley, Killian, Emer P. Reeves, Tomás P. Carroll, & Noel G. McElvaney. (2015). Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment. Expert Review of Respiratory Medicine. 10(2). 207–222. 12 indexed citations
15.
Hurley, Killian, et al.. (2015). Squamous Cell Lung Carcinoma Presenting With Refractory Status Epilepticus: A Case Report of Paraneoplastic Limbic Encephalitis. Respiratory Care. 60(8). e144–e147. 2 indexed citations
16.
Bergin, David A., et al.. (2015). The impact of endoplasmic reticulum stress on neutrophil function in alpha 1 antitrypsin deficiency. BMC Proceedings. 9(S1). 1 indexed citations
17.
Hurley, Killian, Noreen Lacey, David A. Bergin, et al.. (2014). Alpha-1 Antitrypsin Augmentation Therapy Corrects Accelerated Neutrophil Apoptosis in Deficient Individuals. The Journal of Immunology. 193(8). 3978–3991. 51 indexed citations
18.
Bergin, David A., et al.. (2014). The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity. Science Translational Medicine. 6(217). 217ra1–217ra1. 133 indexed citations
19.
Bergin, David A., Killian Hurley, Noel G. McElvaney, & Emer P. Reeves. (2012). Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent. Archivum Immunologiae et Therapiae Experimentalis. 60(2). 81–97. 112 indexed citations
20.
Pickering, Brian W., Killian Hurley, & Brian Marsh. (2009). Identification of patient information corruption in the intensive care unit: Using a scoring tool to direct quality improvements in handover*. Critical Care Medicine. 37(11). 2905–2912. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Geiger Breakdown of academic impact, for papers by Angela J. Yoon Breakdown of academic impact, for papers by Tian Tian Breakdown of academic impact, for papers by Elisabetta Petracci Breakdown of academic impact, for papers by Anne L. King Breakdown of academic impact, for papers by Kaiu Prikk Breakdown of academic impact, for papers by Mengyang Di Breakdown of academic impact, for papers by Ceylan Eken Breakdown of academic impact, for papers by Aris Spathis
Rankless by CCL
2026